Top Pharmaceuticals stocks in Australia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$134.87bn | 34.9 | 1.39% |
NEUNeuren Pharmaceuticals | AU$2.43bn | 15.44 | n/a |
SIGSigma Healthcare | AU$1.99bn | 299.53 | 0.78% |
CUVClinuvel Pharmaceuticals | AU$762.44m | 25.23 | 0.33% |
MYXMayne Pharma | AU$569.53m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$425.46m | n/a | n/a |
PBPProbiotec | AU$235.84m | 25.94 | 2.41% |
RCERecce Pharmaceuticals | AU$130.37m | n/a | n/a |
VLSVita Life Sciences | AU$115.62m | 12.36 | 4.39% |
NXSNext Science | AU$110.84m | n/a | n/a |
BIOBiome Australia | AU$65.72m | n/a | n/a |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
PAAPharmaust | AU$63.59m | n/a | n/a |
VITVitura Health | AU$56.44m | 5.95 | 10.2% |
SPLStarpharma Holdings | AU$49.42m | n/a | n/a |
LGPLittle Green Pharma | AU$39.01m | n/a | n/a |
MVPMedical Developments International | AU$38.41m | n/a | n/a |
IMCImmuron | AU$20.27m | n/a | n/a |
ACRAcrux | AU$18.54m | n/a | n/a |
NOXNoxopharm | AU$18.41m | n/a | n/a |